MINK THERAPEUTICS INC (INKT) Stock Balance Sheet
NASDAQ:INKT - Nasdaq - US6036932019 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 3.23M | 3.37M | 19.64M | 38.89M | 2.69M | |||
| Receivables | N/A | N/A | N/A | 20.00K | 20.00K | |||
| Other Current Assets | 344.90K | 231.10K | 770.00K | 720.00K | 1.38M | |||
| Total Current Assets | 3.58M | 3.60M | 20.40M | 39.63M | 4.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 687.50K | 954.00K | 1.07M | 610.00K | 460.00K | |||
| Total Non-Current Assets | 687.50K | 954.00K | 1.07M | 610.00K | 460.00K | |||
| TOTAL ASSETS | 4.27M | 4.55M | 21.47M | 40.24M | 4.56M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.12M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 1.97M | 5.04M | 4.24M | 1.76M | 1.54M | |||
| Accounts Payable | 2.66M | 3.91M | 5.82M | 3.00M | 3.14M | |||
| Other Current Liabilities | 2.37M | 2.45M | 2.62M | 11.71M | 9.55M | |||
| Total Current Liabilities | 12.12M | 11.40M | 12.68M | 16.47M | 14.22M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 43.82M | |||
| Other Non-Current Liabilities | 13.94M | 11.21M | 9.19M | 0.00 | 380.00K | |||
| Total Non-Current Liabilities | 13.94M | 11.21M | 9.19M | 0.00 | 44.21M | |||
| TOTAL LIABILITIES | 26.06M | 22.61M | 21.87M | 16.47M | 58.43M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -146.95M | -133.40M | -110.94M | -82.95M | -52.74M | |||
| Additional Paid In Capital | 125.82M | 115.77M | 110.83M | 107.35M | 380.00K | |||
| Common Shares | 0.00 | 400.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -662.40K | -431.00K | -290.00K | -630.00K | -1.52M | |||
| Shares Outstanding | 3.97M | 3.46M | 3.39M | 3.35M | 864.50K | |||
| Tangible Book Value per Share | -5.50 | -5.22 | -0.01 | 0.71 | -6.23 | |||
| Total Shareholders' Equity | -21.79M | -18.06M | -400.00K | 23.78M | -53.87M | |||
| TOTAL LIABILITIES AND EQUITY | 4.27M | 4.55M | 21.47M | 40.24M | 4.56M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | -0.81 | |||
| Current Ratio | 0.30 | 0.32 | 1.61 | 2.41 | 0.29 | |||
| Return On Assets (ROA) | -228.21% | -493.33% | -130.37% | -75.07% | -356.14% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -127.04% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21